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Dopamine transporterThe deﬁcit in ability to attribute mental states such as thoughts, beliefs, and intentions of another person
is a key component in the functional impairment of social cognition in schizophrenia. In the current
study, we compared the ability of persons with ﬁrst episode schizophrenia (FE-SZ) and individuals with
schizophrenia displaying symptomatic remission (SZ-CR) to decode themental state of otherswith healthy
individuals and schizoaffective patients. In addition, we analyzed the effect of dopamine-related genes
polymorphism on the ability to decode the mental state of another, and searched for different genetic
signatures. Our results show that overall, individuals with schizophrenia performedworse in the “Reading
theMind in the Eyes” (eyes) test, a simplewell-deﬁned task to infer themental state of others than healthy
individuals. Within the schizophrenia group, schizoaffective scored signiﬁcantly higher than FE-SZ, SZ-CR,
and healthy individuals. No difference was observed in performance between FE-SZ and SZ-CR subjects.
Interestingly, FE-SZ and SZ-CR, but not schizoaffective individuals, performed worse in decoding negative
and neutral emotional valance than the healthy control group. At the genetic level, we observed a
signiﬁcant effect of the DAT genotype, but not D4R genotype, on the eyes test performance. Our data
suggest that understanding the mental state of another person is a trait marker of the illness, and might
serve as an intermediate phenotype in the diagnostic process of schizophrenia disorders, and raise the
possibility that DA-related DAT gene might have a role in decoding the mental state of another person.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
“Theory of mind” (ToM or “mentalizing”) refers to the cognitive
ability to attribute mental states such as thoughts, beliefs, and
intentions to people, allowing an individual to explain, manipulate,h Laboratory, Mazor Mental,
lty of Medicine, Technion-
1, Israel. Tel.: +972 4 995
).
ital Meiman, a friend and
e, this work would not have
This is an open access article undeand predict behavior. Originally this term was deﬁned in 1978 by
Premack and Woodruff following their work on social cognition in
non-human primates, and was described as the ability to explain
the observed behaviors of others by referring to their mental states.
It is widely accepted that ToMcan be divided into cognitive and affec-
tive aspects (Shamay-Tsoory et al., 2007; Shur et al., 2008). Cognitive
ToM is the ability to make inferences about beliefs and motivations,
while affective ToM refers to the ability to infer what a person is feel-
ing. In other words, cognitive ToM corresponds to knowledge about
others' beliefs or intentions, whereas affective ToM corresponds to
the appreciation of the others' emotional states. The cognitive ToM
network primarily engages the dorsomedial prefrontal cortex, the
dorsal anterior cingulate cortex, and the dorsal striatum, while the
affective ToM network primarily engages the ventromedial andr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
14 H. Tadmor et al. / Schizophrenia Research: Cognition 5 (2016) 13–20orbitofrontal cortices, the ventral anterior cingulate cortex, the amyg-
dala, and the ventral striatum (Abu-Akel and Shamay-Tsoory, 2011).
ToM can be measured by a variety of means, including the
classical Sally-Anne false belief test, the verbal and eye-gaze cues
task, reading the mind in the eyes test (referred to as the eyes test),
and through stories and jokes. For all, the subject's ability to evaluate
and judge the mental state of another is assessed. For example,
the ability to understand that another person has beliefs different
from one's own is measured by the false belief test, while decoding
another's complex mental state is measured by the eyes test
(Aboulaﬁa-Brakha et al., 2011; Baron-Cohen et al., 2001; Brüne, 2005).
A relationship between ToM and schizophrenia was ﬁrst pro-
posed by Frith in 1992. He claimed that several symptoms of schizo-
phrenia could be explained by mentalizing impairment. This led to a
substantial body of researchwhich suggested that ToM is impaired in
individuals with schizophrenia. Two meta-analyses reported a large
magnitude of deﬁcits in a number of ToM tasks in schizophrenic pa-
tients, including the false belief sequencing, false belief stories, the
Hinting, and the “Reading the Mind in the Eyes” (eyes) test (Bora
et al., 2009; Sprong et al., 2007). However, it is unclear whether
deﬁcit in the interpretation of others' emotions, intention, and
beliefs is dependent on the state of the illness or a trait. It has been
argued that delusions could be explained as misinterpretation of
others' intentions, and that the absence of a mental representation
of a patient's own intended action would affect the patient's capacity
to assign mental states to other persons' actions. Thus, ToM deﬁcits
are expected to occur in non-remitted patients with prominent
thought and delusions, whereas remitted patients are predicted to
have preserved ToM abilities, suggesting thatmentalizing deﬁcits de-
pendon the state of the illness (Pousa et al., 2008). On the other hand,
several studies suggested that ToM is altered in ﬁrst degree relatives
(Ho et al., 2015; Irani et al., 2006), in high risk individuals (Bora
and Pantelis, 2013; Stanford et al., 2011), and in individuals
with schizophrenia in remission (Herold et al., 2002). Thus, ToM
dysfunction could be trait dependent andmight serve as a traitmarker
of the disorder.
To extend the understanding of whether the impairment in the
ability to attribute mental states of another person in schizophrenia
is trait or state dependent, we study the ability of persons with ﬁrst
episode schizophrenia and individuals with schizophrenia in remis-
sion to decode the mental state of the other with healthy individuals
and schizoaffective patients using the “Reading theMind in the Eyes”
(eyes) test (Baron-Cohen et al., 2001). This task measures the capac-
ity to discriminate the mental state of others from expressions in the
eye region of the face. It is considered an advanced ToM test, since
participants have to put themselves into the mind of the person
shown in the photograph, and attribute a relevant mental state.
The dopaminergic system is thought to play a major role inmedi-
ating our ability to mentalize (Abu-Akel and Shamay-Tsoory, 2011).
However, only a few studies investigated the molecular genetics of
the dopamine (DA)-related gene in the pathogenesis of ToM. D4 re-
ceptor (D4R) genetic variation predicts preschoolers' developing the-
ory of mind (Lackner et al., 2012), and it was recently linked to
variations in gamma power, a network that increases during cogni-
tive and social–cognitive tasks (Williams and Boksa, 2010). Interest-
ingly, activation of the receptor was shown to enhance gamma
oscillations (Kocsis et al., 2013), suggesting that the D4R might
have a role in regulating cognitive processes (Furth et al., 2013). It
is important to note that the D4 receptor was identiﬁed as a risk fac-
tor gene for schizophrenia (Lung et al., 2009; Shi et al., 2008), and that
the DA acts as a key neurotransmitter in the etiology of schizophrenia
(Seeman, 2009; Stone et al., 2007;Winton-Brown et al., 2014), and in
cognitive dysfunction (Simpson et al., 2010) and emotional process-
ing deﬁcit (Salgado-Pineda et al., 2005). Therefore, we addressed
the possible relations between the D4R exon III polymorphisms andthe ability to decode the other's feeling, and searched for a different
genetic signature. In addition, we studied the effect of a second
major polymorphic DA-related gene— the 3′ VNTR dopamine trans-
porter (DAT), a key regulator of synaptic dopamine uptake, on the
performance of the eyes test.
2. Methods
2.1. Subjects
The study was approved by the Mazor Mental Health Center and
the Israel Ministry of Health ethics committees, and all participants
gave informed consent to take part in the study.
Forty-one clinically stable individuals with schizophrenia (SZ-
CR), 20 ﬁrst episode-persons with schizophrenia (FE-SCZ), and 9 in-
dividuals with schizoaffective (SZ-AF) meeting the DSM-IV criteria
were recruited from the open and closed wards of Mazor Mental
Health Center, Akko, Israel. The exclusion criteria were: 1) drug or al-
cohol abuse, 2) mental retardation, and 3) organic brain pathology.
Patients underwent a clinical differential diagnosis using the Struc-
ture Clinical Interview for DSM disorders (SCID) and their positive
and negative symptoms were evaluated using the Positive and Nega-
tive Symptom Rating Scale (PANSS). Clinical and sociodemographic
data were collected from the electronicmedical records of the recruit-
ed patients and included the following variables: age, sex, education,
military service, ethnicity, age of onset, number of hospitalizations,
duration of the illness, and family history.
Two hundred healthy individuals without psychiatric history were
recruited from Ort Brauda College of Engineering, Karmiel, Israel. The
inclusion criteria were physically healthy without drug or alcohol
abuse. Sociodemographic information from self-reported data was col-
lected, and included age, sex, education, military service, and ethnicity.
2.2. Reading the mind in the eyes test
“Reading the Mind in the Eyes” (eyes test) test was developed by
Baron-Cohen et al. (2001) as a tool to evaluate the ability to infer the
mental state of another person. In this task, participants are present-
ed with 36 still pictures of the eye region of faces illustrating emo-
tionally charged or neutral mental states. They were then asked to
choose which of four words best described what the person in the
picture was thinking or feeling. This task is considered an advanced
ToM test since the participants need to imagine themselves in the
mind of the person shown in the picture. One limitation of the test
is that the participants only decode the relevantmental state without
predicting or explaining the action of the other person. The score on
the eyes test is calculated as the total number of correctly identiﬁed
mental states. In addition, we adopted the three-factor model that
was described by Vellante et al. (2012). In brief, the model is based
on classiﬁcation of the 36 pictures to positive, negative, or neutral
valence. Positive valence included 8 items (playful, fantasizing,
thoughtful, friendly, interested, ﬂirtatious, conﬁdent), negative
valence included 12 items (upset, worried, regretful, accusing,
doubtful, preoccupied, deﬁant, hostile, cautious, distrustful, nervous,
suspicious), and 16 itemswere included in the neutral valence (desire,
insisting, uneasy, despondent, cautious, skeptical, anticipating, contem-
plative, decisive, tentative, pensive, interested, reﬂective, serious, con-
cerned). Percentage of correct answerswas calculated for each valence.
2.3. 3′ VNTR dopamine transporter and dopamine D4 receptor exon III
polymorphism genotyping assays
DNA was extracted from blood samples of individuals with
schizophrenia or from saliva of healthy individuals following the
manufacturer's instructions (Fermentas, Life Science, Waltham, MA,
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Master Mix (Promega, Madison, WI, USA) and set of primers previ-
ously described by Vandenbergh et al. (1992) and Mayseless et al.
(2013) were used to determine the 3′ VNTR DAT and D4R polymor-
phisms, respectively. PCR conditions were as follows: an initial dena-
turation step at 94 °C for 2min, followedby35 cycles of denaturation at
94 °C for 10 s, annealing at 63 °C for 30 s and extension at 72 °C for 30 s.
The reactionproceeded tohold at 72 °C for 6min. ThePCRproductswere
electrophoresedon1.5%agarosegel andvisualizedbyethidiumbromide.
The genotypes of the 3′ VNTR DAT and D4R alleles were
determined based on the number of the tandem repeats. In order to
maximize the genetic analysis the D4R gene variation was divided
into short (≤4) and long (≥5) repeats as previously done by others
(Das et al., 2011; Lackner et al., 2012).
2.4. Statistical analysis
For baseline comparison between the groups (as presented in
Table 1), continuous variables were compared using two-sided t-
test, while categorical variables were compared using Pearson's Chi-
square test or Fisher's exact test. Association between groups, genetic
polymorphism and eyes test scores were tested using multivariateTable 1
Demographic, clinical and genetics data.
Variable category Variable SZ-CR (41)
Demographic
Age, yrs.: mean (SD) 35.6 (10.0)
Education, yrs.: mean (SD) 11.8 (2.2)
Gender: n (%)
Men 34 (83%)
Women 7 (17%)
Nationality: n (%)
Jewish 33 (81%)
Arab 8 (19%)
Ethnicity: n (%)c
Ashkenazi 17 (55%)
Non-Ashkenazi 14 (45%)
Clinical
Onset, yrs.: mean (SD) 25.1 (7.3)
Years of illness: mean (SD) 11.0 (7.2)
No. of hospitalizations: mean (SD) 6.2 (5.0)
PANSS scales score: mean (SD)
Positive items 21.9 (6.4)
Negative items 26.2 (5.8)
General items 48.3 (7.4)
Total 96.1 (14.7)
Smoking status: n (%)
Yes 24 (60%)
No 16 (40%)
Genetic
DAT polymorphism: n (%)
Homozygote 9/9 6 (17%)
Homozygote 10/10 17 (49%)
Heterozygote 9/10 12 (34%)
D4R polymorphism: n (%)
Short allele 21 (62%)
Long allele 13 (38%)
Abbreviations: DAT, dopamine active transporter; D4R, dopamine D4 receptor; PANSS, posit
SZ, ﬁrst episode schizophrenia; CT, control group SD, standard deviation.
a Post hoc comparisons revealed that the SZ and SZ-AF groups were signiﬁcantly older th
b Post hoc comparisons revealed that the control group had signiﬁcantly more years of e
c This variable is relevant only for Jewish participants.
d Post hoc comparisons revealed that the FE-SZ group length of illness was signiﬁcantly s
e Post hoc comparisons revealed that the FE-SZ group number of hospitalizationswas sign
schizoaffective comparisons).
f Post hoc comparisons revealed that the FE-SZ group PANSS-positive score was signiﬁca
g Post hoc comparisons revealed that SZ-AF PANSS-negative score was signiﬁcantly lowe
h Post hoc comparisons revealed that FE-SZ group PANSS-general score was signiﬁcantly
i Post hoc comparisons revealed that the ﬁrst episode group PANSS-total score was signiﬁ
total score of SZ-CR group was signiﬁcantly higher that the SZ-AF group (p = 0.001).linear regression models. These models included the main indepen-
dent variables of interest (i.e. group or group and polymorphism) to-
gether with relevant background variables that signiﬁcantly were
different between the groups, and signiﬁcantly associated with the
performance in the eyes test (speciﬁc descriptions of eachmodel con-
struction appear in the following Results section). Speciﬁc post-hoc
comparisons between groups of interest were performed on the pre-
dicted eyes test scores yielded by the regression analyses, and follow-
ed by Bonferroni correction for multiple testing. Effect sizes for
speciﬁc comparisons were calculated by converting the t statistic to
Pearson's r statistic (Field, 2007) then to Cohen's d measure of effect
size (Borenstein et al., 2009), andwere interpreted as small (d=0.1),
medium (d = 0.5), or large (d = 0.8) (Cohen, 1992). All analyses
were performed using IBM-SPSS 20.
3. Results
3.1. Between group demographic data
As described above, 270 subjects participated in the study — 70
individuals with schizophrenia (referred to as SZ) and 200 healthy
controls (referred to as CT). Among the SZ, 41 were diagnosed asSZ-AF (9) FE-SZ (20) Controls (200) p-value
41.6 (8.3) 26.4 (4.9) 26.5 (7.5) b0.001a
11.3 (2.2) 12.0 (1.6) 13.8 (2.6) b0.001b
b0.001
7 (78%) 16 (80%) 106 (54%)
2 (22%) 4 (20%) 92 (46%)
0.1
9 (100%) 12 (60%) 146 (73%)
0 (0%) 8 (40%) 53 (27%)
0.02
5 (56%) 11 (92%) 67 (46%)
4 (44%) 1 (8%) 79 (54%)
26.1 (8.3) 25.5 (4.7) NA 0.91
15.4 (7.9) 1.1 (0.6) NA b0.001d
8.5 (6.9) 1.0 (0.0) NA b0.001e
17.3 (4.0) 41.7 (4.6) NA b0.001f
17.8 (5.2) 22.8 (5.8) NA 0.001g
45.9 (5.4) 58.5 (6.2) NA b0.001h
77.2 (12.6) 122.9 (10.4) NA b0.001i
b0.001
7 (78%) 14 (70%) 46 (23%)
2 (22%) 6 (30%) 153 (77%)
0.71
0 (0%) 4 (20%) 22 (16%)
5 (63%) 7 (35%) 55 (39%)
3 (37%) 9 (45%) 64 (45%)
0.18
2 (25%) 14 (70%) 78 (61%)
6 (75%) 6 (30%) 50 (39%)
ive and negative syndrome scale; SZ, chronic schizophrenia; SZ-AF, schizoaffective; FE-
an the other groups (p b 0.001 for all comparisons).
ducation than the schizophrenic groups (p b 0.001, p = 0.02, p = 0.02, respectively).
horter than the other schizophrenic groups (p b 0.001 for all comparisons).
iﬁcantly smaller than the other schizophrenic groups (p b 0.001 for SCZ, p = 0.001 for
ntly higher than the other schizophrenic groups (p b 0.001 for all comparisons).
r than the other schizophrenic groups (p = 0.001).
higher than the other schizophrenic groups (p b 0.001 for all comparisons).
cantly higher than the other schizophrenic groups (p b 0.001 for all comparisons); the
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(referred to as SZ-AF) and 20 were diagnosed as ﬁrst-episode
(referred to as FE-SZ). Table 1 presents demographic, clinical,
and genetic characteristics of the study sample. Overall, individuals
with schizophrenia (SZ) were signiﬁcantly older (F2,263 = 24.4; p b 0.001)
and had fewer years of education (F3,257= 11.1; p b 0.001). Comparedwith
the control group, they also contained a greater proportion of men (Fisher
exact = 17.3; p b 0.001), and more Ashkenazi Jews (Fisher exact = 10.1;
p b 0.02). In addition, smoking was signiﬁcantly more frequent among the
SZ groups (Fisher exact= 40.1; p b 0.001), comparedwith CT group.3.2. Reading the mind in the eyes is impaired in individuals
with schizophrenia
First, we evaluated the ability of the overall SZ group and CT group
to decode the mental state of another using the eyes test. Fig. 1A and
B summarizes the distribution of the test scores of the healthy and
the SZ, respectively. In order to test the association between groups
(SZ/CT) and the eyes test scores, four multivariate linear regression
models were constructed. One for each eyes test parameter (eyes
test total score and positive, negative, and neutral valences), that
served as the dependent variables. The independent variables in
each model were combined with variables found to be signiﬁcantly
different between the groups (Table 1), and associated with the
eyes test parameters. These variables included smoking status, gen-
der, years of education and age (See Supplementary Table 1 for uni-
variate associations between these variables and eyes test
parameters). Analysis revealed that the SZ group performed signiﬁ-
cantly worse in all eyes test parameters, except positive valence
(Eyes test total score: β=−0.34, t =−4.4, p b 0.001; Negative va-
lence: β=−0.33, t =−4.3, p b 0.001; Neutral valence: β=−0.29,
t =−3.6, p b 0.001; See Supplementary Table 2 for the full models'
details). As expected, on average SZ individuals yielded lower pre-
dicted eyes test total score than healthy individuals (20.3 [SE = 0.1]Fig. 1. Individualswith schizophrenia are impaired in decoding the emotional state of others.
C) Estimated mean differences in total eyes test score ± SEM between overall schizophreniand 23.8 [SE= 0.04], respectively; p b 0.001, d= 3.95, Fig. 1C). In ad-
dition, SZ decoded fewer negative (48.5% [SE= 0.4] and 62.2% [SE=
0.1], respectively; p b 0.001, d = 4.74, Fig. 2A), and neutral (60.4%
[SE = 0.3] and 70.5% [SE = 0.1], respectively; p b 0.001, d = 4.45,
Fig. 2B) valences than the control group, with large effect sizes for
all comparisons. Interestingly, no difference in decoding positive va-
lence between the comparison groups was found (Fig. 2C).
Next, we compared the ability of individuals with chronic schizo-
phrenia (SZ-CR), schizoaffective (SZ-AF) and ﬁrst episode (FE-SZ)
with the CT group to decode themental state of another. Multivariate
regression model's construction was similar to that described above,
with the CT group serving as the reference group. Analysis revealed
that SZ-CR and FE-SZ individuals performed signiﬁcantly worse
than the CT group in all eyes test parameters (Fig. 3A–D). However,
the SZ-AF group performedbetter than the CT group in decoding pos-
itive, neutral, but not negative valence (Eyes test Total score: β=
0.17, t = 2.5, p = 0.01; Positive valence: β = 0.23, t = 3.1,
p b 0.001; Neutral valence: β= 0.14, t = 2.0, p = 0.04; See Supple-
mentary Table 3 for the full models' details). On average, the SZ-AF
group yielded higher predicted eyes test total score than the CT
group (26.8 [SE = 0.2] and 23.8 [SE = 0.0] respectively; p b 0.001,
d = 1.26, Fig. 3A). In addition, SZ-AF participants performed
better in decoding positive (80.6% [SE = 0.9] and 63.1 [SE = 0.1],
respectively; p b 0.001, d = 2.28, Fig. 3B) and neutral (80.6% [SE =
0.6] and 70.5 [SE = 0.1], respectively; p b 0.001, d = 1.78, Fig. 3C)
valences than healthy individuals, with large effect sizes for all
comparisons. However, no difference was found between SZ-AF
individuals and CT in decoding negative valence (Fig. 3D). More-
over, their performance, in all eyes test parameters, was also sig-
niﬁcantly better than SZ-CR and FE-SZ participants (Fig. 3A–D).
Taken together, these data support the notion that SZ-CR and
FE-SZ, but not SZ-AF, patients are impaired in decoding the
other's complex mental state, and suggest that this impairment
is associated with the reduction in the performance in decoding neg-
ative and neutral valences.Healthy volunteers (A) and schizophrenic patients (B) total eyes test score distribution.
a groups and control group. **p b 0.001.
Fig. 2.Decoding negative and neural valences is altered in the schizophrenia patients group. Estimatedmean differences of presented correct choices± SEM (A) negative emotional
valence, (B) neutral emotional valence, and (C) positive emotional valence. **p b 0.001.
Fig. 3. Schizoaffective individuals performed better in the eyes test. (A) Estimated mean differences in total eyes test score ± SEM between individuals with schizophrenia ﬁrst
episode, schizoaffective, and healthy subjects. Estimated mean differences of presented of correct choices ± SEM (B) negative emotional valence, (C) neutral emotional valence,
and (D) positive emotional valence. *p b 0.5, **p b 0.001, ***p b 0.0001.
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Patients' positive and negative symptoms were recorded using
the positive and negative score scale (PANSS, Table 1). PANSS scales
scores of FE-SZ were signiﬁcantly higher (Positive: F2,61 = 96.6;
p b 0.001; Negative: F2,61 = 8.2; p = 0.001; General: F2,61 = 19.7;
p b 0.001; Total: F2,59 = 44.3; p b 0.001) compared with SZ-CR and
SZ-AF groups. In addition, SZ-AF patients' PANSS-negative score was
signiﬁcantly lower than that of the SZ-CR group (p=0.001). In addi-
tion and as expected, FE-SCZ patients had signiﬁcantly fewer years of
illness (F2,65 = 23.4; p b 0.001) and fewer hospitalizations (F2,61 =
11.7; p b 0.001, Table 1). Overall, a signiﬁcant inverse correlation
was found between the eyes test score (Pearson's r = −0.38 p =
0.002), positive valence (Pearson's r =−0.28, p = 0.003), neutral
valence (Pearson's r =−0.38 p = 0.002), and negative symptoms.
Since the PANSS measures were correlated with both the clinical
sub-groups and the eyes test scores, secondary regression analyses
were performed within the SZ participant only, with SZ-CR serving
as the reference group, together with PANSS scores. This analysis re-
vealed the same pattern of results described under Section 3.2: the
SC-AF group manifested higher eyes total score (β= 0.40, t = 3.2,
p b 0.001), positive valence (β=0.30, t = 2.2, p= 0.03) and neutral
valence (β=0.30 t = 2.5, p = 0.04), compared to the SZ-CR and the
FE-SZ groups (full models have not been presented since this analysis
is considered secondary).
3.4. Association between groups, genetic proﬁle, and performance in the
eyes test
Analysis of common allelic variant of the 3′ VNTR DAT polymor-
phism (9 and 10 times 48 bp repeat; 9R and 10R, respectively) re-
vealed that there is no difference in allelic frequency between CT
and the SZ groups (Table 1, DAT: Fisher exact = 3.8; p = 0.71;
D4R: Fisher exact = 4.7; p = 0.18). Association analysis between
groups (SZ and CT), DAT polymorphism (homozygotes 10R/10R [re-
ferred to as 10R/10R], heterozygotes 9R/10R [referred to as 9R/10R]
and homozygotes 9R/9R [referred to as 9R/9R]) and the eyes test
scores was performed using a 3-block multivariate linear regression.
The ﬁrst block included the group main effects and DAT polymor-
phism. The second block added the effects of background variables
(see Section 3.2 above), while the third block added the effect of
the interaction terms (see Supplementary Table 4 for entire models'
details). The analyses revealed signiﬁcant effects for main effects
models only (Models 1 and 2 in Supplementary Table 3), but not
for themodel included the interaction terms (Model 3 in Supplemen-
tary Table 3). A main effect for group was found in the eyes test total
score (β=−0.30, t =−3.3, p b 0.001) and for the negative (β=
−0.30, t = −3.3, p b 0.001) and neutral (β = −0.27, t = −2.9,
p = 0.004) valences. These results replicated the results of 2-group
analysis described above (see Section 3.2), and indicate that SZ pa-
tients scored below the CT group in these eyes test parameters
irrespectively of their 3′VNTRDATgenotype. In addition, a signiﬁcant
main effect for polymorphism was found in the eyes test total
score (β=−0.15, t =−2.1, p = 0.04), and neutral valence score
(β= −0.16, t = −2.1, p = 0.04), indicating that 9R/9R genotype
carrier, irrespective of their clinical state (either SZ or CT), performed
signiﬁcantly worse in the eyes test compared to the other polymor-
phism groups.
Similar multivariate linear regression analyses were performed
in order to examine the associations between groups, D4R polymor-
phism and eyes test parameters. The main effect for group has been
replicated, suggesting that individuals with SZ performed worse
than the CT group in the eyes test irrespective of their DR4 genotype
(see Supplementary Table 5 for full models' details). However,
no main effect for polymorphism was detected. Interestingly, asigniﬁcant interaction effect was found in the ability to decode posi-
tive valance (β=0.32, t = 2.9, p = 0.004). Results indicated that in-
dividuals with SZ carrying the D4R long allele decodedmore positive
emotion valances than CT individuals who carry the same allele. In
addition, SZ individuals carrying the D4R short allele decoded less
positive valances compared with healthy individuals carrying the
same genotype.
4. Discussion
Impaired affective and non-affective face perception in schizo-
phrenia has been widely reported (Li et al., 2010; Velakoulis et al.,
2006). In the current study we report that individuals diagnosed
with schizophrenia performed worse in the eyes test and scored on
average signiﬁcantly lower than healthy individuals in decoding neg-
ative and neutral emotional valances. These ﬁndings are consistent
with the notion that poor mentalizing or poor processing of facial
emotion information is impaired in overall individuals with schizo-
phrenia (Brüne, 2005). However, within the schizophrenia diagnosed
groups, no signiﬁcant difference in the performance of the
eyes test was found between ﬁrst episode persons (FE-SZ) and indi-
viduals with chronic schizophrenia (SZ-CR). On the other hand,
schizoaffective persons (SZ-AF) performed better in decoding the
mental state of another, and scored signiﬁcantly higher than FE-SZ,
SZ-CR, and healthy individuals. In addition, our study pinpoints the
difference in the ability to process positive, negative, and neutral
emotional valence between the different diagnosis groups and
healthy individuals. SZ-CR and FE-SZ individuals, but not SZ-AF par-
ticipant, performedworse in decoding negative and neutral emotion-
al valance than the healthy control group. SZ-AF patients performed
better in decoding positive valence than healthy individuals and SZ-
CR, while recognition of positive facial valence was similar between
SZ-CR, FE-SZ, and healthy individuals. Our results suggest that the
presence of mood symptoms in SZ-AF individuals is related to better
processing of facial information, andmight indicate thatmood abnor-
mality increases the sensitivity to social cues. This ﬁnding is consis-
tent with previous results. Chen et al. (2012) reported that SZ, but
not SZ-AF individuals, exhibited deﬁcient performance in both fear
and happiness discrimination. Moreover, enhanced accuracy in
decoding themental state of otherswas reported in dysphoric college
students (Harkness et al., 2005), while individuals with elevated
levels of depression recognized facial expression more accurately
and faster than individuals with mild depression symptoms (Wu
et al., 2012). Future studies are needed to assess the relationship be-
tween emotional recognition and mood disorders symptoms and
state in comparison with other diagnostic groups. It is important to
note that the small size of the study groups, especially the SZ-AF
group, is a major limitation of the study; therefore, future studies are
necessary to validate the initial ﬁnding in larger diagnostic groups.
Schizophrenia is a heterogeneous disorder and various
subgroupingmethods have been used based on different theories re-
garding the relationship between mentalizing and symptomatology.
Clinical ﬁndings strongly suggest that the impairment of individuals
with schizophrenia in social interaction is related to their reduced
capacity to effectively engage in communication. Furthermore, Frith
(1992) suggested that mentalizing in schizophrenia patients is
compromised because of their failure to monitor their own and
other persons' mental states and behavior, which may account for
many positive and negative symptoms in schizophrenic disorders.
However, Herold et al. (2002) reported contradictory ﬁndings of
ToM deﬁcits in schizophrenia patients whose positive and negative
symptoms were not signiﬁcant. On the other hand, individuals with
schizophrenia at remission and their healthy relatives were observed
to have impaired ToM abilities (Anselmetti et al., 2009; Modinos
et al., 2010). Others found that the siblings of individuals with
19H. Tadmor et al. / Schizophrenia Research: Cognition 5 (2016) 13–20schizophrenia performed signiﬁcantly worse than healthy participants on
theory of mind tests (Bora and Pantelis, 2013; Ho et al., 2015; Janssen
et al., 2003). In the current studywe report that there is no signiﬁcant dif-
ference in the performance of the eyes test between FE-SZ individuals and
SZ. Nor havewe found any correlation between characteristics of the state
of the illness such as the age of onset, duration of the disease, and number
of hospitalizations. Thus, our study supports the idea that alterations in
decoding the mental state of others in people with psychosis are a trait
marker of the illness, and suggests that the associated neural systems can
be investigated as a candidate intermediate phenotype for schizophrenia.
Numerous studies indicated the dopaminergic system as a major
contributor to emotional and facial expression recognition. For exam-
ple, emotional perception is dependent on several brain structures
such as the limbic system and frontal cortex that are subject to dopa-
mine innervation (Salgado-Pineda et al., 2005). At the genetic levels,
the catechol-O-methyltransferase (COMT) gene rs2020917 and
rs737865 SNPs were associated with cognitive ToM performance,
while the COMT gene rs5993883 SNP was related to affective ToM
in healthy individuals (Xia et al., 2012). In addition, in healthy sub-
jects the response to negative facial expression was inﬂuenced by
the genetic variation in dopamine (DA) neurotransmission associat-
ed with the COMT genotype (Smolka et al., 2005). To further investi-
gate the molecular genetics role of the dopaminergic system in
mental state decoding, we investigated, in a small group of patients,
whether 3′ VNTR DAT or the D4R polymorphism repeats affect the
ability to decode the mental state of the other. We found that overall
individuals (both schizophrenia persons and healthy individuals)
carrying the 9R/9R allelic repeats performed worse in the eyes test
compared with 9R/10R heterozygote or 10R homozygote genotypes.
In addition, we report that individuals with schizophrenia carrying
the D4R long allele decoded more positive emotional valances,
whereas patients with the short allele decoded less positive valances.
Studies suggest that the DAT polymorphism has effect on its tran-
scription and protein availability. The DAT 9R carriers have higher
striatal DAT availability than do 10R homozygotes, suggesting lower
dopamine concentration in the striatum (van de Giessen et al.,
2009). Since striatal dopaminergic activity is associated withmotiva-
tional processes and emotional processing (Badgaiyan, 2010), our
data suggest reduced sensitivity to decode the mental state of anoth-
er in DAT 9R/9R carriers. However, contradictory results have been
observed for the relative gene expression of the each allele (Costa
et al., 2011); therefore, further studies are needed before deﬁnitive
conclusions can be reached. Taken together, our and others' ﬁndings
suggest an association of the dopaminergic risk genes on emotional
perception and ToM in individuals with schizophrenia, and raise the
possibility that DA-related DAT and COMT risk genes might have a
role in the process of understanding the mental state of the other.
However, we cannot rule out an indirect effect of the DA-related
risk genes on the ability to decode themental state of others. This as-
sociation can be driven by other systems such as learning, reward and
motivation that were reported to be in interaction with ToM, and
under the dopamine circuit's regulation. In addition to the complex
interactions between the dopaminergic systems and mentalizing,
Bosia et al. (2011) reported that individuals with schizophrenia car-
rying the C allele of the serotonin 1A receptor, a well characterized
functional polymorphism, performed better in ToM compared to
theG allele carriers.Moreover, the activation of ToMnetworks during
mentalizing of emotions is altered in healthy individuals carrying
the psychosis risk allele in the gene ZNF804A, a gene that has been
found to be associated with schizophrenia (Walter et al., 2011).
Thus, other schizophrenia risk genes might also contribute to the
mental state decoding impairment, and further genetics studies
need be considered.
To conclude, our goal was to investigate the possibility that the
ability to attribute mental states of another person in schizophreniais trait rather than state dependent. We show that individuals with
FE-SZ do not differ from individuals with SZ in their ability to decode
the mental state of others. Thus, understanding the mental state of
others might not be inﬂuenced by the state of the patient's psychosis.
We also provide some preliminary evidence on the role of the DA-
related DAT gene in emotional recognition deﬁcit in schizophrenia.
In addition, we provide preliminary evidence that SZ-AF individuals
might differ in their ability to decode themental state of other people
from SZ and FE-SZ patients, indicating that mentalizing might be an
intermediate phenotype in the diagnostic process of schizophrenia
disorders. One should note that the small size of the study groups se-
riously limits the signiﬁcance of the results, and in order to reach a
conclusion, future studies are necessary with larger sample sizes.
Furthermore, an extensive body of research has linked neuro-
cognition andToM(Cooket al., 2013; Shur et al., 2008), suggesting a re-
lationship between cognitive performance and the ability to decode
the emotional state of another. Further studies are needed to study
this relationship in and between the different diagnostic groups.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.scog.2016.06.001.
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